Brand Name(s): Robaxin; Robaxisal
CAS nº: 532-03-6
(meth oh kar' ba mole)

About Methocarbamol

This new site is dedicated exclusively to methocarbamol.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or pharma industry professional, you can now find out everything you need to know about methocarbamol, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total methocarbamol experience! 

Why is this medication prescribed?

Methocarbamol is a muscle relaxant that exerts its effect by acting on the central nervous system (ie the nerves that control the muscles) rather than on the muscles themselves.

This medicine can be used in any condition where painful muscle spasms should be reduced for patient comfort (intervertebral disc disease, for example) but it is also considered the treatment of choice for metaldehyde (snail bait) poisoning, a condition causing severe muscle twitching. Methocarbamol is also used in the treatment of tetanus (which is characterized by muscle rigidity) and strichnine poisoning (characterized by stiffness and seizuring).

Robaxin®, Robaxacet®, and Robax Platinum®  are trade names for methocarbamol. It is structurally related to guaifenesin. 

See more Product Info

Latest News

FDA Safety Labeling Changes

The U.S. Food and Drug Administration (FDA) approved in May revisions to drug safety labeling to...

[more]

Able Laboratories Receives FDA Approval for Methocarbamol Tablets, USP 500mg and 750mg

Able Laboratories, Inc. (Nasdaq:ABRX) (BSE:AAB), today announced that it has received Food and Drug...

[more]

Tremorgenic mycotoxicosis in four dogs from a single household

Mycotoxins are fungal metabolites that induce undesirable effects. The effects of these mycotoxins...

[more]

Major Company to Stop Making Generic Oral Products

Bethesda, MD — American Home Products Corp. (AHP) has announced that it will stop manufacturing...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.